Amphastar Pharmaceuticals (AMPH) Goodwill & Intangibles (2016 - 2025)
Historic Goodwill & Intangibles for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $628.9 million.
- Amphastar Pharmaceuticals' Goodwill & Intangibles rose 38.27% to $628.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $628.9 million, marking a year-over-year increase of 38.27%. This contributed to the annual value of $628.6 million for FY2024, which is 28.56% up from last year.
- As of Q3 2025, Amphastar Pharmaceuticals' Goodwill & Intangibles stood at $628.9 million, which was up 38.27% from $628.9 million recorded in Q2 2025.
- In the past 5 years, Amphastar Pharmaceuticals' Goodwill & Intangibles ranged from a high of $635.2 million in Q2 2023 and a low of $42.9 million during Q3 2022
- Over the past 5 years, Amphastar Pharmaceuticals' median Goodwill & Intangibles value was $626.4 million (recorded in 2024), while the average stood at $352.3 million.
- Its Goodwill & Intangibles has fluctuated over the past 5 years, first tumbled by 468.34% in 2022, then soared by 137903.73% in 2023.
- Over the past 5 years, Amphastar Pharmaceuticals' Goodwill & Intangibles (Quarter) stood at $45.0 million in 2021, then decreased by 2.6% to $43.8 million in 2022, then skyrocketed by 1329.79% to $626.8 million in 2023, then increased by 0.29% to $628.6 million in 2024, then grew by 0.06% to $628.9 million in 2025.
- Its Goodwill & Intangibles stands at $628.9 million for Q3 2025, versus $628.9 million for Q2 2025 and $628.7 million for Q1 2025.